New York Life Investment Management LLC Revance Therapeutics, Inc. Transaction History
New York Life Investment Management LLC
- $9.66 Billion
- Q4 2024
A detailed history of New York Life Investment Management LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 295,670 shares of RVNC stock, worth $759,871. This represents 0.01% of its overall portfolio holdings.
Number of Shares
295,670
Previous 137,594
114.89%
Holding current value
$759,871
Previous $353,000
115.01%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
208Shares Held
81.6MCall Options Held
2.26MPut Options Held
5.48M-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA5.94MShares$15.3 Million9.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I05.1MShares$13.1 Million0.78% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...